Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
378.00    4.70 (1.26%)
Bid:
381.10
Ask:
381.30
Spread: 0.20 (0.052%)
Market Cap: £7.77b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

Pension Funding Plan

28 Nov 2012 09:11

RNS Number : 1915S
Marks & Spencer Group PLC
28 November 2012
 



 

28 November 2012

 

Marks and Spencer Group plc Announces Funding Plan

for its UK Defined Benefit Pension scheme

 

 

Marks and Spencer Group plc ("the Company") today announces that it has reached agreement with the Company's Pension Scheme Trustees on the terms of the triennial actuarial valuation as at 31 March 2012.

 

The valuation of the Company's UK defined benefit pension scheme ("Pension Scheme") at 31 March 2012 has resulted in a deficit of £290m. This represents a substantial reduction in deficit from £1.3bn as at 31 March 2009.

 

The improvement reflects the additional contributions made to the Pension Scheme following the 2009 valuation together with strong investment growth and sound risk management. The valuation is based on the same methodology adopted for the 2009 valuation but incorporates the latest asset values and revised assumptions in relation to longevity.

 

The Company and the Trustees have agreed a 10 year funding plan, which includes annual cash contributions of £28m per annum from 2013/14 to 2016/17, a reduction on the previously agreed £60m per annum until 2017/18. The remaining balance is expected to be met by investment returns on the scheme's existing assets. These contributions are in addition to the payments under the existing pension property partnership.

 

 

 

Statements made in this announcement that look forward in time or that express management's beliefs, expectations or estimates regarding future occurrences and prospects are "forward-looking statements" within the meaning of the United States federal securities laws. These forward-looking statements reflect Marks & Spencer's current expectations concerning future events and actual results may differ materially from current expectations or historical results. Any such forward-looking statements are subject to various risks and uncertainties, including failure by Marks & Spencer to predict accurately customer preferences; decline in the demand for products offered by Marks & Spencer; competitive influences; changes in levels of store traffic or consumer spending habits; effectiveness of Marks & Spencer's brand awareness and marketing programmes; general economic conditions or a downturn in the retail or financial services industries; acts of war or terrorism worldwide; work stoppages, slowdowns or strikes; and changes in financial and equity markets.

 

 

Contacts

Investor Relations:

Majda Rainer +44 (0)20 8718 1563

Richard Harris +44 (0)20 8718 9688

 

Corporate Press Office: +44 (0)20 8718 1919

Out of hours calls: +44 (0)20 8718 2000

 

-Ends-

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEANFPAEXAFEF
Date   Source Headline
28th Nov 20232:55 pmRNSDirector/PDMR Shareholding
9th Nov 202310:29 amRNSDirector/PDMR Shareholding
8th Nov 20237:00 amRNSHalf-year Report
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:01 pmRNSDirector/PDMR Shareholding
2nd Oct 20239:00 amRNSTotal Voting Rights
28th Sep 20233:18 pmRNSDirector/PDMR Shareholding
20th Sep 20233:33 pmRNSHolding(s) in Company
20th Sep 20239:00 amRNSDirector/PDMR Shareholding
19th Sep 20239:01 amRNSDirector/PDMR Shareholding
1st Sep 20239:00 amRNSTotal Voting Rights
30th Aug 202310:34 amRNSDirector/PDMR Shareholding
16th Aug 20233:00 pmRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSTrading Update and Outlook for the Year
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 202311:33 amRNSDirector/PDMR Shareholding
7th Jul 20234:18 pmRNSDirector/PDMR Shareholding
4th Jul 20232:13 pmRNSResult of AGM
3rd Jul 20239:00 amRNSBlock listing Interim Review
3rd Jul 20239:00 amRNSTotal Voting Rights
28th Jun 20232:01 pmRNSDirector/PDMR Shareholding
19th Jun 20234:41 pmRNSDirector/PDMR Shareholding
8th Jun 20235:01 pmRNSHolding(s) in Company
7th Jun 20232:56 pmRNSHolding(s) in Company
6th Jun 202310:00 amRNSAnnual Financial Report
1st Jun 202312:19 pmRNSDirector/PDMR Shareholding
1st Jun 20239:00 amRNSTotal Voting Rights
24th May 20237:00 amRNSFinal Results
2nd May 20239:00 amRNSTotal Voting Rights
28th Apr 202310:40 amRNSDirector/PDMR Shareholding
3rd Apr 20239:00 amRNSTotal Voting Rights
28th Mar 20232:04 pmRNSDirector/PDMR Shareholding
20th Mar 20233:53 pmRNSHolding(s) in Company
1st Mar 20239:00 amRNSTotal Voting Rights
28th Feb 202310:23 amRNSDirector/PDMR Shareholding
24th Feb 20239:00 amRNSDirectorate Change
1st Feb 20239:00 amRNSTotal Voting Rights
30th Jan 202310:18 amRNSDirector/PDMR Shareholding
16th Jan 20231:35 pmRNSHolding(s) in Company
16th Jan 202310:30 amRNSChange to Board Committee Membership
13th Jan 20234:16 pmRNSHolding(s) in Company
12th Jan 20237:00 amRNSChristmas 2022/2023 Trading
5th Jan 20234:02 pmRNSHolding(s) in Company
3rd Jan 20239:00 amRNSTotal Voting Rights
3rd Jan 20239:00 amRNSBlock listing Interim Review
29th Dec 202210:40 amRNSDirector/PDMR Shareholding
13th Dec 202210:37 amRNSDirector Declaration
12th Dec 20221:45 pmRNSDirectorate Change
9th Dec 20223:27 pmRNSDirector/PDMR Shareholding
1st Dec 20229:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.